ResearcherTexas A&M UniversityActive in the last 2 years

Sneha H. Johnson

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5112467204. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 2

A novel NR4A2-HuR axis promotes pancreatic cancer growth and tumorigenesis that is inhibited by NR4A2 antagonists. Co-author DOI 10.62347/kcpn6689 ↗
Nuclear Receptor 4A2 (NR4A2/NURR1) Regulates Autophagy and Chemoresistance in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/2767-9764.crc-21-0073 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Mahsa Zarei · 1 shared paper, 2021 · strength 0.12
- Paper Nuclear Receptor 4A2 (NR4A2/NURR1) Regulates Autophagy and Chemoresistance in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/2767-9764.crc-21-0073 ↗
Ali Vaziri Gohar · 1 shared paper, 2021 · strength 0.12
- Paper Nuclear Receptor 4A2 (NR4A2/NURR1) Regulates Autophagy and Chemoresistance in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/2767-9764.crc-21-0073 ↗
Mehrdad Zarei · 1 shared paper, 2021 · strength 0.12
- Paper Nuclear Receptor 4A2 (NR4A2/NURR1) Regulates Autophagy and Chemoresistance in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/2767-9764.crc-21-0073 ↗
Stephen H Safe · 1 shared paper, 2021 · strength 0.12
- Paper Nuclear Receptor 4A2 (NR4A2/NURR1) Regulates Autophagy and Chemoresistance in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/2767-9764.crc-21-0073 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.